Clinical Trial Supplies Market

Request for customization Inquire Before Buying

Clinical Trial Supplies Market Size, Share And Industry Analysis Report By Services (Logistics, Distribution, Storage, Retention, Packaging, Labeling, Blinding, Manufacturing And Comparator Sourcing); By Phases (Phase 1, Phase 2, Phase 3, Phase 4 AND BA/ BE studies); By Type (Small Molecules, Biologics and Medical devices); By Therapeutic Areas (Oncology, CNS and mental disorders, Cardiovascular diseases, Digestive disorders, Infectious diseases, Metabolic disorders, Immunology and Blood disorders); By End User (Pharma, Biotech, Academia, Investigators, Regulators, Ethics/IRBs, Participants, Data/Tech, Logistics and CROs) - Forecast Year 2024 – 2031

Healthcare // Analytical & Scientific Instrumentation

Number of Pages: 384 Report Format: pdf Report ID: ZBA-892 Publishing Date: - August, 2023

Frequently Ask Question

The Global Clinical Trial Supplies Market Is Forecasted To Grow At A Rate Of 10.1% To USD 7.28 Billion In 2030

Key Factors That Are Driving The Market Growth Include Increasing R&D expenditure of pharmaceutical and biopharmaceutical companies, Increasing number of registered clinical trials, Increasing decentralization of clinical trials

The Clinical Trial Supplies Market Is Led By Logistics & distribution Segment And Is Projected To Account For The Largest Size Of The Clinical Trial Supplies Market From 2022 To 2030

Some Key Players Operating In The Clinical Trial Supplies Market Include Acnos Pharma Gmbh, Adallen Pharma, Almac Group, Ancillare, Lp, Biocair, Capsugel (Acquired By Lonza), Catalent, Inc., Clinical Services International, Clinigen Limited, Corex Logistics, Ct Group Llc, Durbin, Eurofins Scientific, Infosys, Klifo, Liveo Research, Marken (Subsidiary Of Ups), Movianto, N-Side, Parexel International Corporation, Pci Pharma Services, Piramal Pharma Solutions, Pra Health Sciences (Subsidiary Of Icon Plc), Recipharm Ab, Thermo Fisher Scientific